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Figure. MACEs-free survival curves between the patients treated with the
ﬁrst- and second-generation DES.
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19th CardioVascular Summit: TCTAP 2014disease and worse left ventricular dysfunction. Prognostic implications of BBB in
diabetic patients with acute MI have yet to be clariﬁed.
Methods: We analyzed 23,724 patients with acute MI from the Korea Acute
Myocardial Infarction Registry and the Korea Working Group on Myocardial
Infarction Registry. Twelve-month clinical outcome was compared between patients
with BBB and those without BBB according to the presence of DM.
Results: Patients with left BBB (n ¼ 181) were older, more likely to be men, have
hypertension, DM, multi-vessel disease, left ventricular dysfunction, less likely to
have chest pain at presentation and receive percutaneous coronary intervention (PCI)
(67% vs. 86%) and beta blockers. In-hospital mortality was not different between
patients with left BBB and those without left BBB (0.6% vs. 0.5%). However, all-
cause mortality and the rate of major adverse cardiac events (MACE: all-cause
mortality, MI, and repeat revascularization) were higher in patients with left BBB at 1
month (6.6% vs. 1.8%, p < 0.001 and 11.6% vs. 5.9%, p ¼ 0.001) and 12 months
(11.6% vs. 3.7%, p < 0.001 and 27.6% vs. 19.3%, p ¼ 0.005), respectively. Patients
with right BBB (n ¼ 494) were older, more likely to be men, have prior stroke, less
likely to have chest pain at presentation and PCI (81% vs. 86%). In-hospital mortality
was not different between patients with right BBB and those without right BBB (0.4%
vs. 0.5%). All-cause mortality and MACE were similar at 1 month (2.2% vs. 1.8% and
6.5% vs. 5.9%), but higher in patients with right BBB at 12 months (6.3% vs. 3.7%,
p ¼ 0.003) and (22.7% vs. 19.3%, p ¼ 0.035). Diabetics with left BBB, compared to
diabetics without left BBB, had higher prevalence of multi-vessel disease (80% vs.
65%, p ¼ 0.024), which was similar in non-diabetics regardless of the presence of left
BBB. On multivariate analysis, left BBB was associated with 12-month all-cause
mortality in diabetics (hazard ratio: 2.6; 95% conﬁdence interval: 1.25 to 5.25;
p ¼ 0.010), but not in non-diabetics, while right BBB was not an independent
predictor of death regardless of diabetic status.
Conclusion: In patients with acute MI, BBB was associated with worse 12-month
clinical outcome. Particularly in diabetics, left BBB was associated with more
extensive coronary artery disease and higher mortality.
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Background: There is some data that plaque instability precedes the onset of
symptoms in acute myocardial infarction. But it is not known whether the age of
thrombus has any relation to short term clinical outcomes in patients treated with
thrombus aspiration during primary percutaneous coronary intervention (PPCI).
Methods: Consecutive patients of ST elevation myocardial infarction (STEMI) un-
dergoing PPCI with thrombus aspiration were included in the present study. After
passing the wire in the culprit artery, thrombus aspiration was done with a suction
catheter and the material was sent to histopathology lab in 10% formalin. It was
processed and the microscopic sections were categorised into old and fresh thrombus,
according to the existing guidelines. 30 day major adverse cardiac events (MACE)
deﬁned as a composite of death, myocardial infarction (MI) and revascularisation was
correlated with age of the thrombus, after adjusting for confounding factors.
Results: Baseline characteristics like age, sex, presence of risk factors and background
statin therapy were similar between the two groups. Of the total number of 79 patients
who presented within 6 hours of symptom onset, the aspirated material was insufﬁ-
cient in 7 patients. Out of the remaining 72 thrombi aspirated 40 (55.6%) showed lytic
changes and were classiﬁed as old. The rest 32 (44.4%) thrombi belonged to the fresh
category with intact leukocytes and ﬁbrin. There was no MACE at 30 days in either of
the categories.
Conclusion: In patients of STEMI undergoing PPCI short term clinical outcomes are
excellent irrespective of the age of the thrombus. However this study needs further
evaluation in a larger population with long term follow up.
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Background: Slow-ﬂow/no re-ﬂow phenomenon is mainly induced by distal embo-
lization of thrombus and necrotic core during PCI of AMI, and is associated with
unfavorable long-term clinical outcomes. Firstly, we perform aspiration thrombec-
tomy for AMI patients, but we will sometimes experience slow ﬂow or no re-ﬂow
phenomenon during coronary intervention. However, the high risk patients of distal
embolization are not well understood. Various imaging modalities have failed to
detect high risk patients of distal embolization for whom distal protection might be
beneﬁcial. We examined if the patients who require multiple aspiration to achieve
TIMI III ﬂow are high risk of patients of distal embolization.
Methods: Consecutive patients with AMI (n¼135) who received PCI with ﬁlter-
type distal protection device (Filtrap) were prospectively included. We classiﬁed
them into two groups by numbers of aspirations required to achieve TIMI III
coronary ﬂow: single aspiration (Group A, n¼92) and multiple aspiration (GroupJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORAB, n¼43). We compared between the groups the frequency of ﬁlter slow ﬂow or no
re-ﬂow phenomenon and of distal embolization captured by ﬁlter device. Distal
embolization was evaluated by the pathological examination of collected material
in the ﬁlter device.
Results: Although the distal embolization of thrombus was not deferent between
the groups (100% vs. 96%, P¼0.16), that of plaque debris was more frequent in
Group B than in Group A (95% vs. 18%, P<0.0001). Filter slow ﬂow/ no-reﬂow
phenomenon also occurred more frequently in Group B than in Group A (95% vs.
18%, P<0.0001).
Conclusion: Requirement of multiple aspirations to achieve TIMI III coronary ﬂow
was associated with high frequency of distal embolization and of ﬁlter slow ﬂow/
no-reﬂow.
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Background: The aim of the study was to compare the efﬁcacy and safety of second-
generation drug-eluting stent (DES) with ﬁrst-generation DES in primary percuta-
neous coronary intervention (PCI) for ST-segment elevation myocardial infarction
(STEMI).
Methods: A total of 1022 patients with STEMI undergoing primary PCI were
enrolled from the Korean Multicenter Endeavor (KOMER) trial (Cypher, n¼201;
Taxus, n¼204; Endeavor-Sprint, n¼204), the Gil PCI registry (XienceV, n¼85;
Endeavor-Resolute, n¼76), and the Korean Nobori registry (Nobori, n¼252). We
excluded the patients who had been cardiogenic shock at admission, received
thrombolytic therapy or had no follow-up data at 1 year. Major adverse cardiac
event (MACE), deﬁned as the composite of cardiac death, recurrent myocardial
infarction (MI), or target lesion revascularization at 1 year, were compared in
patients treated with the ﬁrst-generation DES (Cypher, Taxus and Endeavor-
Sprint; n¼609) versus second-generation DES (Xience V, Endeavor-Resolute and
Nobori; n¼413).
Results: Baseline characteristics were similar between patients treated with the ﬁrst-
and the second-generation DES except history of MI which was more prevalent in the
second-generation DES group than in the ﬁrst-generation DES group (6.1% vs. 2.0%,
p¼0.001). The cumulative incidence of MACE rate was 6.4% for the ﬁrst-generation
DES group and 1.2% for the second-generation DES group at 1-year follow-up
(p<0.001, Figure). One-year recurrent MI and TLR rate were signiﬁcantly lower in
the second-generation DES group than those in the ﬁrst-generation DES (0.2% vs.
2.0%, p¼0.016; 0.2% vs. 2.8%, p¼0.002, respectively). However, cardiac death rate
was not signiﬁcantly different in the both group (0.7% vs. 1.6%, p-0.261). There was a
trend towards a lower rate of stent thrombosis (deﬁnite or probable) in patients treated
with the second-generation DES compared to the ﬁrst-generation DES (1.6% vs.
0.2%, p¼0.058).
Conclusion: As compared with the ﬁrst-generation DES, the use of the second-gen-
eration DES in patients with STEMI undergoing PCI showed lower rates of MACE,
recurrent MI and TLR at 1 year. There was a trend towards a lower rate of stent
thrombosis with the second-generation DES compared to the ﬁrst-generation DES.L/Acute Coronary Syndrome: STEMI, NSTE-ACS S5
